Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 0.86 | 1.36 |
NAV | ₹10.60 | ₹203.15 |
Fund Started | 25 Jul 2024 | 07 May 2007 |
Fund Size | ₹61.73 Cr | ₹89383.23 Cr |
Exit Load | - | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 5.72% | 5.86% |
3 Year | - | 24.50% |
5 Year | - | 26.05% |
1 Year
3 Year
5 Year
Equity | 100.06% | 93.94% |
Cash | -0.06% | 6.06% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
BSE Ltd. | 4.91% |
Suzlon Energy Ltd. | 3.49% |
Hero Motocorp Ltd. | 3.49% |
Persistent Systems Ltd. | 3.08% |
Dixon Technologies (India) Ltd. | 3.08% |
PB Fintech Ltd. | 2.92% |
Coforge Ltd. | 2.88% |
Cummins India Ltd. | 2.85% |
The Federal Bank Ltd. | 2.82% |
HDFC Asset Management Company Ltd. | 2.65% |
Name | Assets |
|---|---|
Max Financial Services Ltd. | 4.46% |
AU Small Finance Bank Ltd. | 3.70% |
Indian Bank | 3.54% |
The Federal Bank Ltd. | 3.38% |
Balkrishna Industries Ltd. | 3.37% |
Fortis Healthcare Ltd. | 3.19% |
Coforge Ltd. | 3.11% |
Hindustan Petroleum Corporation Ltd. | 2.96% |
Glenmark Pharmaceuticals Ltd. | 2.67% |
Ipca Laboratories Ltd. | 2.52% |
Name | Satish Dondapati | Chirag Setalvad |
Start Date | 20 Nov 2025 | 28 Jun 2014 |
Name
Start Date
Description | The scheme seeks to provide returns that, before expenses, corresponding to the total returns of the securities as represented by the underlying index, subject to tracking errors. | The scheme seeks to provide long-term capital appreciation/income by investing predominantly in Mid-Cap companies. |
Launch Date | 25 Jul 2024 | 07 May 2007 |
Description
Launch Date